First cannabis-derived drug authorised for France

France has for the first time approved prescription use of a drug derived from cannabis—a mouth spray used to treat multiple sclerosis (MS) symptoms, the government said Thursday.

The medicine, called Sativex, is already authorised in several European neighbours, but had remained off-limits in France due to a ban on any products derived from the marijuana plant.

The health ministry published a policy change last June, opening the door for medical use of the drug's active ingredients.

The first market authorisation was given on Wednesday by the National Agency for Drug Safety (ANSM), the ministry said.

Sativex, produced by the British firm GW Pharmaceuticals, has been approved for use in alleviating muscle stiffness and spasms from MS.

"The market authorisation is an interim step" before the drug becomes available from pharmacies, but on prescription only, said a ministry statement.

The spray's main active ingredients are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

ANSM official Nathalie Richard said Sativex was not recommended for breastfeeding or pregnant women or people with a history of psychosis.

Medical cannabis use is already a reality in countries like the Netherlands, Spain, Italy, Germany and Britain, Canada, Australia and some American states.

In Canada, Sativex is also used to alleviate pain associated with cancer.

New York Governor Andrew Cuomo announced Wednesday he will authorise medical marijuana use, making his the 21st US state to do so.

add to favorites email to friend print save as pdf

Related Stories

Pot-based prescription drug looks for FDA OK

Jan 23, 2012

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by ...

Washington state approves rules for pot industry

Oct 16, 2013

Washington became the second U.S. state to adopt rules for the recreational sale of marijuana Wednesday, setting what advocates hope will become a template for the drug's legalization around the world.

Czechs in quandary over legal medical marijuana

Nov 15, 2013

(AP)—Just three years ago, the only thing that Zdenek Majzlik knew about cannabis was that it's good stuff for making rope. Today, the 67-year-old retired nuclear power plant employee is an experienced ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments